Amount Raised
$50 Million
Round Type
Funding Round
IndiaManufacturingBiotechnologyDescription
Biotech company Enzene Biosciences, a subsidiary of Mumbai-based drug maker Alkem Laboratories, has raised $50 million (or roughly Rs 408 crore) in fresh equity funding from Eight Roads Ventures and healthcare investor F-Prime Capital.In a press statement, Enzene said it would leverage the fresh funds to enhance its manufacturing capabilities and drive expansion in its core market of India and the US.Pune-based Enzene focuses on producing biosimilars, novel biologics, synthetic peptides and phytopharmaceuticals.Enzene has plans to set up a research and development as well as manufacturing centre in the US.“We have been tracking the broader biologics segment in India for several years, seeking disruptive technologies, products and management teams. Companies like Enzene position India well at the forefront of global biotech innovation,” said Prem Pavoor, senior partner, head of India and healthcare investments, Eight Roads Ventures.Discover the stories of your interestBlockchain5 StoriesCyber-safety7 StoriesFintech9 StoriesE-comm9 StoriesML8 StoriesEdtech6 StoriesEight Roads, which is backed by US financial services major Fidelity, has deployed more than $1.5 billion of venture capital in the country, and has backed the likes of software platforms Whatfix, Icertis and online pharmacy startup Pharmeasy.In May 2022, Eight Roads launched its first dedicated $250 million healthcare and life sciences fund for India“Internationally, the US and Europe remain key markets for Enzene with the aim of expanding into new geographies in their mission to become the most sought after CDMO (contract development & manufacturing organization),” said Ketan Patel, partner at F-Prime Capital.In India, F-Prime has invested in the likes of medtech startup Core Diagnostics, therapeutics venture Immuneel and Pharmeasy.
Quick answer
Enzene raised $50 Million in a Funding Round round, dated January 29, 2023. Enzene is based in India.
- How much did Enzene raise?
- Enzene raised $50 Million in a Funding Round round on January 29, 2023.
- What does Enzene do?
- Enzene is a Continuously Innovative Development and Manufacturing (CIDMO™) partner supporting innovators and biosimilar developers across discovery, development, and commercial supply.
- Where is Enzene based and how big is it?
- Enzene is based in India. Fundz records about 501 employees.
- Who are the decision-makers at Enzene?
- Fundz holds 1 contact at Enzene, including the Associated Vice President. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Enzene, and when
A new round usually means Enzene is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Enzene raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Enzene, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Enzene. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Enzene raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Enzene raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.